Invest ESSEX will once again be flying the flag for the county at the Biotechnology Innovation Organisation (BIO) International Convention 2019 in Philadelphia, Pennsylvania from 3rd to the 6th June 2019.

Invest ESSEX will be representing the life science clusters in the UK Innovation Corridor, which includes Greater London, Essex and Cambridge. Invest ESSEX will be part of the OneNucleus stand at BIO – one of 19 stands covering the UK and Northern Ireland.

Invest ESSEX will be represented by Dave Russell-Graham on the One Nucleus pod at BIO 2019. To contact Dave, email: David.RussellGraham@investessex.co.uk

To keep up to date on Invest ESSEX’s Twitter coverage of BIO 2019, follow: @investessex

Encouraging companies to locate in Essex

Essex is seeing major investment in the life sciences industry, with projects such as Harlow Science Park underlining the potential of the county and its position within the UK Innovation Corridor, which already has a global reputation for scientific research.

Harlow Science Park began construction in October 2018 and is a new destination for business focusing on all areas of science, technology, research and innovation. Harlow Science Park offers 27 acres of Grade ‘A’ development opportunities in a town which includes occupiers such as Public Health England, Pearson, Teva Pharmaceutical Industries, Arrow Electronics and Raytheon.

Public Health England’s (PHE) new £450m state-of-the-art public health science campus and headquarters relocation to Harlow in 2021 will further cement Essex’s growing life sciences reputation.

Just some of the life sciences companies based in Essex include Cambridge Business Weekly’s ‘Killer 50 hottest disruptive technology companies’ such as Arecor, AstraZeneca, Cambridge Epigenetix, Evonetix and NodThera.

Invest ESSEX has been successful in assisting key industry players at Chesterford Research Park in Saffron Walden, which offers advanced laboratory and office space for biotechnology and pharmaceutical companies, and has been particularly instrumental in attracting three companies to the facility: Evonetix, Enplas and Arecor.

Among the other success stories at Chesterford are Domainex, who will have their own pod at BIO. In 2018, the drug discovery Contract Research Organisation (CRO) was named in the second annual top 1000 list of Europe’s fastest growing companies, published by the Financial Times (FT 1000). See here for more info about Domainex.

Why Essex is a key location in the UK life science cluster

Essex’s location makes it well-placed to collaborate with the Cambridge and London life science clusters, as part of the UK Innovation Corridor. This allows business to have all the benefits of London on its doorstep but without the costs incurred by running a business from the capital.

According to a report published in May 2018 by pharmaceutical giant AstraZeneca, the Cambridge life sciences cluster could contribute an extra £1bn a year to the UK economy by 2032, with up to 6,000 additional jobs being created in that time.

Essex is primed for future transport links between the county and London, and with its London Stansted and London Southend airports introducing new routes all the time, as well as ports at London Gateway, Tilbury and Harwich, the lure of the county from a business perspective continues to strengthen.

Located at the heart of the UK Innovation corridor, London Stansted Airport is the UK’s third largest airport and is currently undergoing a five-year £600m revamp. In November 2018, plans to increase its capacity to 43 million passengers per year were approved. As a result, this expansion will create 5,000 new jobs and boost the local economy by £1bn. In 2019, Emirates announced that they would launch a daily flight between London Stansted Airport and Dubai International Airport. Testament to the success of the service was the addition of a second daily flight in 2019.

London Stansted is a critical economic asset for Essex and its increasing route network is a major attraction to international companies looking to invest and establish a presence in the region. Companies have chosen Stansted because of links to serve their burgeoning European and International markets.

David Rooke
Location Services Director
Invest ESSEX

The life sciences sector is heavily reliant on airport facilities, with the speed of air freight delivery crucial for ‘just-in-time’ and high-value goods such as pharmaceuticals.

Also located within the established London-Stansted-Cambridge Corridor, will be the soon-to-open Harlow Science Park, creating a new life sciences facility as part of the Harlow Enterprise Zone.

London Stansted aerial image

The UK life science offer at BIO

The BIO International Convention is hosted by the Biotechnology Innovation Organisation, which represents more than 1,100 biotechnology companies, academic institutions, state biotechnology centres and related organisations across the United States and in more than 30 other nations. Overall, there will be 17,000 + attendees at BIO overall and 19 stands representing the UK.

Among the UK activity at BIO is the UK BIO International Networking Breakfast on Monday 3rd June organised by the Northern Health Science Alliance. The UK Reception co- sponsored by AZ, BIA, Invest Northern Ireland and Welsh Government will be held at 18:30 on Tuesday 4 June.

BIO is very much one of the major international events that provides an ideal opportunity to position Harlow Science Park in the thinking of many of the world’s top industry figures, advisors and influencers as part of the UK’s conference pavilion. Aligning Harlow Science Park as a key element of the Greater London-Cambridge-East of England corridor that is One Nucleus combined with the re-launch of the London-Stansted-Cambridge corridor as the UK’s Innovation Corridor could facilitate Harlow and Harlow Science Park being positioned right in the middle of the UK’s version of Medical Alley.

Dave Russell-Graham
Inward Investment Manager (Life Sciences & Healthcare)
Invest ESSEX

Invest ESSEX will be represented by Dave Russell-Graham on the One Nucleus pod at BIO 2019. To contact Dave, email: David.RussellGraham@investessex.co.uk

To keep up to date on Invest ESSEX’s Twitter coverage of BIO 2019 follow: @investessex

For more information on the Essex life sciences sector see here.

Find out more about the BIO 2019 convention here.